Table 1 Demographic data and lipid profiles in different BMI groups

From: Obesity, altered oxidative stress, and clinical correlates in chronic schizophrenia patients

Variable

Low BMI group (n = 34)

High BMI group (n = 55)

F or χ2

df

P-value

Age (years)

51.2 ± 6.8

52.1 ± 8.7

0.272

1,87

0.603

Education (years)

9.6 ± 2.5

9.8 ± 2.5

0.157

1,87

0.693

Male/female

26/8

34/21

2.054

1

0.171

Duration of illness (years)

27.9 ± 8.7

28.3 ± 9.5

0.054

1,87

0.816

Age of onset (years)

23.6 ± 5.7

23.6 ± 6.2

0.000

1,87

0.989

Hospitalization numbers

3.8 ± 1.9

4.0 ± 3.0

0.150

1,87

0.699

BMI (kg/m2)

21.1 ± 2.3

27.0 ± 2.2

144.9

1,87

0.000

Daily AP dose (mg) (CPZ equivalent)

338.6 ± 133.3

315.4 ± 151.0

0.541

1,87

0.464

Risperidone/clozapine

12/22

10/45

3.306

1

0.081

TG

1.4 ± 0.7

1.9 ± 1.1

6.557

1,86

0.012

HDL-c

1.1 ± 0.1

1.1 ± 0.2

2.384

1,86

0.126

LDL-c

2.8 ± 0.6

3.1 ± 0.6

4.317

1,86

0.041

APOA

1.2 ± 0.1

1.2 ± 0.1

1.370

1,86

0.245

APOB

0.7 ± 0.1

0.8 ± 0.5

3.467

1,86

0.066

CHO

4.3 ± 0.8

4.6 ± 1.1

1.942

1,86

0.167

  1. AP antipsychotic, CPZ chlorpromazine, BMI body mass index, TG triglycerides, TC total cholesterol, HDL-c high-density lipoprotein cholesterol, LDL-c low-density lipoprotein cholesterol, CHO cholesterol